Abstract:<bold>Objective</bold> To study the effectiveness of DNA-RNA molecules linked with aptamers as hybrid vectors to target tumor cells and introduce functional RNA molecules into cells, as well as their effects on tumor cells.<bold>Methods</bold> Design and synthesize short complementary DNA and RNA molecules, and assemble them into DNA-RNA hybrid chains; connect AS1411 aptamer as targeting molecule, and then connect p21 saRNA and TIGIT siRNA as drug molecules, denoted as P21 saRNA and TIGIT siRNA , constitute a hybrid vector, the general structural formula is AS1411-DNA/RNA-sxRNA; detect whether AS1411-DNA/RNA-sxRNA can target and enter tumor cells and its effect on the survival, migration, invasion and apoptosis of tumor cells.<bold>Results</bold> Equimolar parts of the designed hybrid vector were added to the hybridization buffer system and incubated at a specific temperature. TBM polyacrylamide gel electrophoresis detected the successful assembly of AS1411-DNA/RNA-sxRNA; AS1411-DNA/RNA-sxRNA hybridized carriers are also showed good anti-degradation stability under the condition of 10% serum; observed under fluorescence microscope and laser confocal microscope, there were a large number of green fluorescent signals on the surface and in the cell of SKOV3 cells, and the hybrid carrier successfully entered the tumor cells. After the hybrid carrier incubated, at the mRNA level, the expression of p21 gene (2.14 +/- 0.25) was nearly 2 times that of the control group (1.02 +/- 0.10), P<0.05, the expression of TIGIT gene (0.63 +/- 0.09) was lower than that of the control group (1.09 +/- 0.15), P<0.05, at the protein level, the expression of p21 gene (1.57 +/- 0.16) was more than 1.5 times that of the control group (1.10 +/- 0.09), P<0.05, the expression of TIGIT gene (0.61 +/- 0.12) was lower than that of the control group (1.01 +/- 0.07) , P<0.05. The CCK-8 experiment showed that the proliferation ability of ovarian cancer cells decreased significantly (P<0.05) in the P21 saRNA (3.10 +/- 0.13) and TIGIT siRNA (2.91 +/- 0.13) groups, compared with the blank control group (3.67 +/- 0.15); the experimental results showed that the healing rate of P21 saRNA group ((42.53 +/- 2.90)%) and TIGIT siRNA group ((36.23 +/- 3.43)%) were significantly lower than those of the blank control group ((76.47 +/- 3.64)%), P<0.05; Transwell assay showed that: P21 saRNA group (128.25 +/- 5.36), TIGIT siRNA group (119.50 +/- 8.79) were lower than the control group (186.5 +/- 8.56), P<0.05. And the invasion ability: P21 saRNA group (145.5 +/- 9.45), TIGIT siRNA group (112.25 +/- 5.63) were also significantly lower than the control group (202.50 +/- 10.12), P<0.05; apoptosis rate: P21 saRNA group ((11.74 +/- 2.47)%) and TIGIT siRNA group ((17.12 +/- 2.04)%) were significantly higher than the control group ((5.66 +/- 1.44)%), P<0.05.<bold>Conclusion</bold> The prepared AS1411-DNA/RNA-sxRNA hybrid vector can effectively target tumor cells, carry functional small RNAs into tumor cells, regulate the expression of target genes, and inhibit the proliferation, invasion and migration of tumor cells. The results provide an experimental basis for using DNA-RNA conjugated AS1411 aptamer as a hybrid carrier as a targeting tool to target and kill tumor cells expressing NCL protein on the surface.

Effect of Activation of P21 Induced by Targeted Sarna on Proliferation and Chemosensitivity to Cispaltin in Lung Cancer Cells

p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell

Anti-Cancer Effects of P21waf1/Cip1 Transcriptional Activation Induced by Dsrnas in Human Hepatocellular Carcinoma Cell Lines

[Activation of P21(waf1/cip1) by Small Activating RNA Inhibits Cell Proliferation and Induces Apoptosis in BEL-7402 Hepatoma Cell].

Up-regulation of P21waf1/cip1 by Sarna Induces G1-phase Arrest and Apoptosis in T24 Human Bladder Cancer Cells.

Development of Therapeutic dsP21-322 for Cancer Treatment.

The Effects of RNAi Technique and (or) P53 Gene on the Proliferation of Lung Cancer Cells in Vitro

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

Demystifying the Mechanistic and Functional Aspects of P21 Gene Activation with Double-Stranded RNAs in Human Cancer Cells

Construction of P21sarna Eukaryotic Expression Vector and Identification of Its Function in Urinary Cancer Cells

The Effect of P21 Antisense Oligodeoxynucleotides on the Radiosensitivity of Nasopharyngeal Carcinoma Cells with Normal P53 Function.

Study of RNAi Targeting Epidermal Growth Factor Receptor on Lung Adenocarcinoma A549 Cell Line Growth and Sensitivity to Cisplatin

Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine

Biological Behaviors and Chemosensitivity of NSCLC A549 Cells after IGF-I R Gene Silencing by Targeting RNAi in Vitro

Effect of Long Intergenic Noncoding RNA-p21 Knockdown on Radiosensitivity of Hypoxic Tumor Cells

Anti-tumor Study of DNA-RNA Nanocarriers Linked to AS 1411 Aptamer

The Co-Transfection of P16ink4a and P14arf Genes into Human Lung Cancer Cell Line A549 and the Effects on Cell Growth and Chemosensitivity

Knockdown of Insulin-Like Growth Factor 1 Receptor Enhances Chemosensitivity to Cisplatin in Human Lung Adenocarcinoma A549 Cells

[Effects of RNA Interference on Epidermal Growth Factor Receptor Expression in SPC-A-1 Cells].

Effect of RNAi-mediated USP22 gene silencing on the growth of human nasopharyngeal carcinoma xenograph in nude mice

[Effect of Down-Regulation of Survivin Gene on Apoptosis and Cisplatin Resistance in Cisplatin Resistant Human Lung Adenocarcinoma A549/CDDP Cells].